New eye drops aim to control wet macular degeneration
Disease control
Completed
This study tested three different doses of SYL1801 eye drops in 99 people with wet age-related macular degeneration (AMD). The goal was to see if the drops are safe and help maintain or improve vision. Participants received the eye drops and were monitored for changes in eyesight…
Phase: PHASE2 • Sponsor: Sylentis, S.A. • Aim: Disease control
Last updated May 17, 2026 08:53 UTC